SCHEMBL18544672

SCHEMBL18544672

N#Cc1cccnc1/C=C(\N)c1ccncc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
KDM4E B2RXH2 3/20 0.36
RECQL P46063 1/20 0.36
CDC7 O00311 1/20 0.34
POLB P06746 1/20 0.33
HDAC1 Q13547 1/20 0.33
LRRK2 Q5S007 1/20 0.33
ALDH1A1 P00352 2/20 0.32
NEK2 P51955 1/20 0.32
PLK1 P53350 1/20 0.32
HPGD P15428 2/20 0.31
CLK1 P49759 1/20 0.31
CLK2 P49760 1/20 0.31
CLK3 P49761 1/20 0.31
CDK5 Q00535 1/20 0.31
DYRK1A Q13627 1/20 0.31
CDK5R1 Q15078 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
DYRK1B Q9Y463 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20991108 0.84 NPC1 (0.39) HTTLRRK2ALDH1A1HPGDCYP1A2
SCHEMBL30684932 0.74 ELANE (0.41) HTTKDM4ERECQLPOLBLRRK2
SCHEMBL19620498 0.73 LRRK2 (0.39) HTTKDM4ERECQLPOLBLRRK2
SCHEMBL2978064 0.69 LRRK2 (0.41) HTTKDM4EPOLBLRRK2ALDH1A1
SCHEMBL4062071 0.69 LRRK2 (0.41) HTTKDM4ERECQLPOLBHDAC1
SCHEMBL5026268 0.67 RECQL (0.60) KDM4ERECQLPOLBALDH1A1NEK2
SCHEMBL17610285 0.67 RECQL (0.60) KDM4ERECQLPOLBALDH1A1NEK2
SCHEMBL5026264 0.67 RECQL (0.60) KDM4ERECQLPOLBALDH1A1NEK2
SCHEMBL3288734 0.64 CNR2 (0.49) HTTCDC7HDAC1LRRK2ALDH1A1
SCHEMBL31147724 0.64 CYP11B1 (0.43) KDM4EPOLBLRRK2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017031215-A1 PROCESS DEVELOPMENT OF A PYRIDINE-CONTAINING NK-1 RECEPTOR ANTAGONIST ELI LILLY AND COMPANY (US) 2017-02-23 WO disclosed